These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 5096649)

  • 1. Diuretics and emergency management of hemophilioid disorders.
    Hoak JC; Christie DM
    N Engl J Med; 1971 Nov; 285(21):1204. PubMed ID: 5096649
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined factor VIII and IX inhibitors in a non-haemophilic patient: successful treatment with immunosuppressive drugs.
    Carmassi F; Giannarelli C; De Giorgi A; De Negri F
    Haemophilia; 2007 Jan; 13(1):106-7. PubMed ID: 17212735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired factor IX deficiency in the nephrotic syndrome.
    Natelson EA; Lynch EC; Hettig RA; Alfrey CP
    Ann Intern Med; 1970 Sep; 73(3):373-8. PubMed ID: 5455988
    [No Abstract]   [Full Text] [Related]  

  • 4. Christmas disease (clotting factor IX deficiency) and the presentation of a carcinoid tumour in an inguinal hernia.
    Prentice AG
    Br J Clin Pract; 1980 Mar; 34(3):80-2. PubMed ID: 7378266
    [No Abstract]   [Full Text] [Related]  

  • 5. Markers of hypercoagulability in patients with hemophilia B given repeated, large doses of factor IX concentrates during and after surgery.
    Santagostino E; Mannucci PM; Gringeri A; Tagariello G; Baudo F; Bauer KA; Rosenberg RD
    Thromb Haemost; 1994 Jun; 71(6):737-40. PubMed ID: 7974341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Presence of inactive factor ix in variants of hemophilia, type B, and in carriers of hemophilia B].
    Elodi S
    Minerva Med; 1975 Jun; 66(42):2037-43. PubMed ID: 1138213
    [No Abstract]   [Full Text] [Related]  

  • 7. [Surgical procedures in hemophilia B].
    Ziemski JM; Lopaciuk S; Poszwiński P; Uszyński L
    Pol Tyg Lek; 1973 Sep; 28(38):1462-5. PubMed ID: 4750068
    [No Abstract]   [Full Text] [Related]  

  • 8. [A young male mongrel with hemophilia-B (Christmas disease)].
    Kooistra HS; Slappendel RJ
    Tijdschr Diergeneeskd; 1991 Mar; 116(6):281-5. PubMed ID: 2028457
    [No Abstract]   [Full Text] [Related]  

  • 9. Myocardial infarction during factor IX infusion in hemophilia B: case report and review of the literature.
    Najaf SM; Malik A; Quraishi AU; Kazmi K; Kakepoto GN
    Ann Hematol; 2004 Sep; 83(9):604-7. PubMed ID: 15205916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dentition restoration in hemophilia under substitution of AHG concentrates].
    Tetsch P; Esser E
    Dtsch Zahnarztl Z; 1972 May; 27(5):399-404. PubMed ID: 4112700
    [No Abstract]   [Full Text] [Related]  

  • 11. Unintended benefit of anabolic steroid use in hemophilia B leiden.
    Rimmer EK; Seftel MD; Israels SJ; Houston DS
    Am J Hematol; 2012 Jan; 87(1):122-3. PubMed ID: 22038733
    [No Abstract]   [Full Text] [Related]  

  • 12. Immune reactive factor IX in acquired factor IX deficiency.
    Lechner K
    Thromb Diath Haemorrh; 1972 Feb; 27(1):19-24. PubMed ID: 5033668
    [No Abstract]   [Full Text] [Related]  

  • 13. [Capacity of activation of so-called deficient factors in hereditary blood coagulation disorders].
    Mingers AM
    Fortschr Med; 1976 Oct; 94(30):1723-5. PubMed ID: 1086815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor IX Zutphen. A genetic variant of blood coagulation factor IX with an abnormally high molecular weight.
    Bertina RM; Van Der Linden IK
    J Lab Clin Med; 1982 Nov; 100(5):695-704. PubMed ID: 7130828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood coagulation disorders caused by abnormal blood coagulation factors].
    Fiedler H
    Z Arztl Fortbild (Jena); 1972 Jul; 66(13):692-8. PubMed ID: 4636972
    [No Abstract]   [Full Text] [Related]  

  • 16. The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia.
    McMillan CW; Greene WB; Blatt PM; White GC; Roberts HR
    Instr Course Lect; 1983; 32():210-6. PubMed ID: 6443730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings: Electroimmunoassay of human coagulation factor IX in the detection of variants of haemophilia B.
    Orstavik K; Osterud B
    Thromb Diath Haemorrh; 1975 Sep; 34(1):322-3. PubMed ID: 1188733
    [No Abstract]   [Full Text] [Related]  

  • 18. [Non-activated and activated prothrombin complex concentrates, Proplex and Feiba, in the treatment of a hemophilia B patient with high titer inhibitor against factor IX].
    Niiya K; Hirose S; Taguchi H; Miyoshi I
    Rinsho Ketsueki; 1985 Jun; 26(6):980-4. PubMed ID: 3877825
    [No Abstract]   [Full Text] [Related]  

  • 19. Electroimmunoassay of factor IX in patients with liver damage and vitamin K unresponsive coagulation disorder.
    Girolami A; Burul A; Cappellato G; Dal Bo Zanon R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(1):65-71. PubMed ID: 88391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical procedures in unsuspected hemophilia.
    Coy J; Bivins BA; Belin RP
    Arch Surg; 1974 Dec; 109(6):835-6. PubMed ID: 4421034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.